Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In EscondidoInterventional, Open-label, Flexible-dose Extension Study of Brexpiprazole in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Anaheim
Efficacy of a Brief Group Psychoeducation Program Aimed at Patients With Schizophrenia and Their Families: A Clinical Controlled Trial
This study has finished and is no longer accepting participants.
Location not clearly listed
This study has finished and is no longer accepting participants.
In Saint-Etienne
This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with schizophrenia.
This study has finished and is no longer accepting participants.
In BostonTraining-induced Cerebral Reorganization in Schizophrenia
This study has finished and is no longer accepting participants.
In KonstanzCHANGE.A Randomized Clinical Trial of Health Promoting Programme Versus Standard Treatment for Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In CopenhagenSingle-Dose, Open-Label Pilot Study to Explore the Pharmacokinetics, Safety and Tolerability of a Gluteal Intramuscular Injection of a 4-Week Long-Acting Injectable Formulation of Risperidone in Patients With Chronic Stable Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosThis study evaluated the effectiveness of Olanzapine for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AachenSchizophrenia and Physical Exercise: Effect of 20 Weeks of Training in Symptoms and Concentration in Serum IGF-1 and BDNF
This study has finished and is no longer accepting participants.
In São PauloA Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveRandomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype
This study ended early.
In BethesdaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.